Phio Pharmaceuticals Corp’s recently made public that its Chairman, Pres. & CEO Bitterman Robert J acquired Company’s shares for reported $5150.0 on Dec 31 ’25. In the deal valued at $1.03 per share,5,000 shares were bought. As a result of this transaction, Bitterman Robert J now holds 291,421 shares worth roughly $0.34 million.
Then, Bitterman Robert J bought 5,000 shares, generating $5,100 in total proceeds. Upon buying the shares at $1.02, the Chairman, Pres. & CEO now owns 286,421 shares.
Before that, Bitterman Robert J bought 5,000 shares. Phio Pharmaceuticals Corp shares valued at $5,700 were divested by the Chairman, Pres. & CEO at a price of $1.14 per share. As a result of the transaction, Bitterman Robert J now holds 281,421 shares, worth roughly $0.33 million.
A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who began to cover the stock in early August with a ‘”a Buy”‘ rating.
Price Performance Review of PHIO
On Monday, Phio Pharmaceuticals Corp [NASDAQ:PHIO] saw its stock jump 7.34% to $1.17. Over the last five days, the stock has gained 8.33%. Phio Pharmaceuticals Corp shares have fallen nearly -35.00% since the year began. Nevertheless, the stocks have risen 11.43% over the past one year. While a 52-week high of $9.79 was reached on 01/05/26, a 52-week low of $0.97 was recorded on 01/02/26.
Levels Of Support And Resistance For PHIO Stock
The 24-hour chart illustrates a support level at 1.1133, which if violated will result in even more drops to 1.0567. On the upside, there is a resistance level at 1.2133. A further resistance level may holdings at 1.2567.
How much short interest is there in Phio Pharmaceuticals Corp?
A steep rise in short interest was recorded in Phio Pharmaceuticals Corp stocks on 2025-12-15, dropping by -0.15 million shares to a total of 0.2 million shares. Yahoo Finance data shows the prior-month short interest on 2025-11-14 was 0.35 million shares. There was a decline of -72.16%, which implies that there is a negative sentiment for the stock.
